The global demand for molecular microbiological products was valued at over US$ 4.6 Billion in 2019. However, with rising prevalence of various infectious diseases across the world and growing popularity of molecular diagnostic methods, the overall molecular microbiology market size is anticipated to surpass US$ 8.3 Billion by 2024 and projected to grow at around 10% CAGR throughout the forecast period (2022 – 2032)
| Report Attribute | Details |
| Molecular Microbiology Market Projected Growth Rate (2022-2032) | 10% CAGR |
Since the introduction of molecular microbiology, the diagnostic microbiology landscape has changed drastically. It has generated lucrative opportunities for laboratory professionals to advance in molecular diagnostics.
The detection and identification of microorganisms by using conventional microbiological methods is laborious and time consuming. As a result, researchers and medical professionals have changed their preference towards more rapid detection molecular methods. This has brought the molecular microbiology market into limelight.
Molecular microbiology is the branch of microbiology which deals with the molecular mechanisms and physiologic processes of microorganisms and their utilization in the production of essential biotechnology products and medicines such as antibodies and vaccines. It involves the study of microbial biological activities and processes at molecular levels.
Various molecular microbiological methods are being increasingly incorporated in laboratories for the detection and characterization of pathogens which cannot be detected by conventional culture techniques. By using these molecular methods, experts can analyze the molecules that microorganisms possess and generate including DNA, RNA proteins, cellular metabolites and lipids.
Growing adoption of quantitative PCR detection diagnostic kits, pathogenic microorganisms' diagnostic kits etc. for the early detection of various diseases coupled with rising application of molecular microbiological methods across various end use verticals such as hospitals, diagnostic laboratories and research institutes is anticipated to provide a strong thrust to market growth during the forecast period.
Moreover, introduction of diseases-specific, real time PCR kits are expected to further boost the growth of molecular microbiology market during the forthcoming period.
Rising prevalence of infectious diseases, genetic syndromes, tuberculosis etc. worldwide, increasing funding by government and non-government organizations, advances in diagnostic solutions, and rapid expansion of healthcare industry are some of the major factors driving the global molecular microbiology market.
In recent years, molecular microbiology has emerged as the fastest growing discipline which plays a significant role for the early detection and characterization of microorganisms. Adoption of molecular microbiological methods has totally revolutionized the routine diagnostic microbiology by allowing rapid and accurate detection of even those microorganisms that may not be detected by conventional methods.
Rising prevalence of various infectious diseases coupled with growing need for early detection and identification of microorganisms (pathogens) is acting a catalyst for the growth of molecular microbiology market and the trend is likely to continue during the forthcoming years.
Similarly, advancements in molecular diagnostics and introduction of favorable regulatory policies are also slated to assist market growth during the assessment period.
In addition to this, changing methodologies for the early and rapid diagnosis of diseases coupled with rising awareness about infectious diseases and their impact disastrous health impacts is expected to further bolster the growth of molecular microbiology market in the forthcoming years.
Although molecular microbiology is gaining huge momentum across end use verticals, there are certain factors that are likely to hamper market growth during the assessment period. Some of the major growth restraining factors are the high cost of molecular microbiology tests, lack of skilled labor to handle the complexity of devices, and poor penetration of products across various developing and underdeveloped regions.
Owing to the rapid expansion of end use verticals, increasing incidence of infectious diseases, and high awareness levels among people regarding various infectious diseases, their diagnosis and treatment, North America is likely to retain its dominant position in the global molecular microbiology market during the assessment period.
Within North America, the U.S. remains the most lucrative market for molecular microbiology and the trend is likely to continue in the future. Growth in the market is driven by increasing patient pool, rising diagnostic rates, presence of leading market players, growing popularity of molecular diagnostics methods, and easy availability of user-friendly testing solutions.
During the last few years, number of patients suffering from tuberculosis and HIV has risen drastically across the United States. According to the Center for Disease Control and Prevention (CDC), there were around 9025 new cases of tuberculosis reported in the U.S. in 2018. Similarly, the number of HIV diagnoses reached around 37,377 in 2018. This will continue to push the sales of molecular microbiological products like quantitative PCR detection diagnostic kits and pathogenic microorganism diagnostic kits during the forecast period.
According to Future Market Insights, the Asia Pacific molecular microbiology market is poised to grow at a higher CAGR during the forecast period, owing to the rising prevalence of infectious diseases, favorable government policies, and rising healthcare spending.
Demand for quantitative PCR detection diagnostic kits and pathogenic microorganism’s diagnostic kits is increasing at a significant pace across countries like India, China and South Korea due to growing awareness among people regarding the benefits of molecular testing and early detection of pathogens.
Similarly, rapid expansion of healthcare infrastructure coupled with the entry of various regional and international market players is expected to boost the growth of the Asia Pacific market during the forecast period.
Some of the key participants present in the global molecular microbiology market include QIAGEN, Abbott Laboratories, Curetis N.V., F. Hoffmann-La Roche AG, Hologic, Inc., and Agilent Technologies among others.
Leading players are continuously launching novel diagnostic products to help end users in proper detection of numerous diseases and identification of pathogens. Besides this, they have adopted various strategies such as partnerships, collaborations, acquisitions, etc. to increase their market share and expand their global footprint.
| Report Attribute | Details |
| Growth Rate | CAGR of 10% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By Application:
By End User:
By Region:
FMI projects the global molecular microbiology market to grow at around 10% CAGR throughout the forecast period.
The Asia Pacific market is forecast to grow at a higher growth rate during the forecast period.
QIAGEN, Abbott Laboratories, Curetis N.V., F. Hoffmann-La Roche AG, and Hologic, Inc. are some prominent molecular microbiology manufacturersQIAGEN, Abbott Laboratories, Curetis N.V., F. Hoffmann-La Roche AG, and Hologic, Inc. are some prominent molecular microbiology manufacturers
Explore Similar Insights
Molecular Microbiology Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
